Bénédicte Roquebert

Rapid spread of the SARS-CoV-2 Delta variant in some French regions, June 2021

Samuel Alizon, Stéphanie Haïm‐Boukobza, Vincent Foulongne et al. · Eurosurveillance · 2021 · 875 citations · Full text

High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment‐Experienced Patients Infected with Multidrug‐Resistant HIV: Results of the ANRS 139 TRIO Trial

Yazdan Yazdanpanah, Catherine Fagard, Diane Descamps et al. · Clinical Infectious Diseases · 2009 · 237 citations

HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitro

Bénédicte Roquebert, Florence Damond, Gilles Collin et al. · Journal of Antimicrobial Chemotherapy · 2008 · 126 citations

In Vitro Phenotypic Susceptibility of Human Immunodeficiency Virus Type 2 Clinical Isolates to Protease Inhibitors

Delphine Desbois, Bénédicte Roquebert, Gilles Peytavin et al. · Antimicrobial Agents and Chemotherapy · 2008 · 121 citations · Full text

Immunology, Antiviral Drug, Clinical Isolates +17

Human Immunodeficiency Virus Type 1 (HIV-1) Plasma Load Discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 Assays

Florence Damond, Bénédicte Roquebert, Antoine Bénard et al. · Journal of Clinical Microbiology · 2007 · 82 citations · Full text

Monitor Version 1.5, Viral Diagnostics, Mean Values +13